Implant Stability and Peri‐Implant Parameters in Free Vascularized Iliac Graft Transplantation Patients: Report of Three Ameloblastoma Cases

Tözüm, Tolga F.; Sönmez, Erhan; Aşkin, Sezen Büyüközdemir; Tulunoğlu, İbrahim; Şafak, Tunç

doi:10.1902/jop.2010.100339

Cited by 5 publications

(10 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In 3 cases, restoration of missing teeth was achieved by secondary dental implant placement in the bone grafts and by using implant-supported prostheses. Previous studies have demonstrated the advantages of implant placement and subsequent restoration with prostheses for the rehabilitation of oral competence, mastication, speech and facial contour in patients with mandibular defects (25,29,30). …”

Section: Discussionmentioning

confidence: 99%

Treatment of recurrent mandibular ameloblastoma

Infante-Cossio

Prats-Golczer

González-Pérez

et al. 2013

Experimental and Therapeutic Medicine

View full text Add to dashboard Cite

Ameloblastoma is a locally invasive benign odontogenic tumor with a high rate of recurrence in the long term. The authors conducted a retrospective study of patients with mandibular ameloblastoma in order to evaluate recurrent ameloblastoma management. The study included data from 31 patients over a period of 10 years. Data collected included age, gender, tumor location, histological findings, initial treatment, number of recurrences and year of onset, type of treatment of recurrence, reconstruction and follow-up. Recurrences were detected in nine patients (29%). Tumor recurrences appeared at 32 months on average following the initial surgical procedure. Recurrences were associated mainly to inadequate initial therapeutic approach and were treated by bone resection with a safety margin of at least 1 cm beyond the radiographically visible margins. Immediate reconstruction of bone defects was performed with grafts or free flaps.

show abstract

Section: Discussionmentioning

confidence: 99%

Treatment of recurrent mandibular ameloblastoma

Infante-Cossio

Prats-Golczer

González-Pérez

et al. 2013

Experimental and Therapeutic Medicine

View full text Add to dashboard Cite

show abstract

“…Most articles were published after 2013 (25: 71.4%). Four (24%) studies were conducted in India [ 42 , 44 , 55 , 58 ], Turkey [ 27 , 32 , 47 , 49 ] and Brazil [ 37 , 46 , 52 ], 3 (18%) in the USA [ 30 , 35 , 41 ], Spain [ 31 , 50 , 57 ], China [ 28 , 33 , 43 ], Korea [ 38 , 39 , 53 ], 2 (12%) in Italy [ 36 , 48 ], Finland [ 29 , 40 ] and other studies (6%) in Japan [ 54 ], Colombia [ 59 ], Iran [ 56 ], Taiwan [ 25 ], Austria [ 26 ] and Romania [ 45 ] (Tables 2 and 4 ).…”

Section: Resultsmentioning

confidence: 99%

“…A total of 12 (19%) cases were reported as recurrent AM, which were reintervened. It was also observed that 94% of patients had conventional/multicystic AM [ 25 , 27 – 30 , 32 – 49 , 51 – 59 ], and only 4 (6%) cases were diagnosed as unicystic type AM [ 26 , 31 , 42 , 50 ]. The most common histologic variant was the plexiform type (11%) [ 26 , 37 , 39 , 49 ], followed by the follicular variant (8%) [ 26 , 34 , 38 , 45 , 46 ].…”

Section: Resultsmentioning

confidence: 99%

“…The most common histologic variant was the plexiform type (11%) [ 26 , 37 , 39 , 49 ], followed by the follicular variant (8%) [ 26 , 34 , 38 , 45 , 46 ]. The most affected anatomical region was the mandible (94%) [ 25 , 27 – 49 , 51 – 56 , 58 , 59 ], mainly the posterior (58.3%) and left side of the face (42%), followed by the posterior maxilla (75%) [ 26 , 50 , 57 ]. Clinically, 97% of patients were asymptomatic (did not report pain) [ 25 – 51 , 53 , 54 , 57 – 59 ], and 91% presented cortical expansion [ 25 – 41 , 44 – 47 , 49 – 52 , 55 , 56 , 59 ].…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Implant-supported prosthetic rehabilitation after Ameloblastomas treatment: a systematic review

Alarcón-Sánchez,

Becerra-Ruíz,

Yessayan

et al. 2023

BMC Oral Health

View full text Add to dashboard Cite

Background Ameloblastoma (AM), the benign counterpart of ameloblastic carcinoma, is a benign odontogenic tumor of epithelial origin, naturally aggressive, with unlimited growth potential and a high tendency to relapse if not adequately removed. Patients with AM treated surgically can benefit from dental implant therapy, promoting oral rehabilitation and improving their quality of life. The present study aimed to determine the survival rate of dental implants placed after surgical treatment of patients affected by AM. In addition, there were two secondary objectives: 1) To evaluate which dental implant loading protocols are most frequently used and 2) To determine the type of prosthetic restoration most commonly used in these patients. Methods The Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines were followed during the study. Searches were performed in three databases (PubMed/MEDLINE, Scopus, and Google Scholar) until November 2023. Additionally, the electronic search was enriched by an iterative hand search of journals related to oral pathology and medicine, maxillofacial surgery, and oral prosthodontics and implantology. Only reports and case series in English from January 2003 to date were included. The Joanna Briggs Institute tool (JBI-Case Reports/Case Series) was used for the study quality assessment. Results The total number of patients and implants studied were 64 and 271, respectively, all with surgically treated AM. The patient’s ages ranged from 8 to 79 years, with a mean (SD) age of 37.3 ± 16.4. Fifty-three percent were male and 47% were female. The range of follow-up duration was 1 to 22 years. An implant survival/success rate of 98.1% was reported. In addition, most of them were conventionally loaded (38.3%). Hybrid implant-supported fixed dentures were the most commonly used by prosthodontists (53%). Conclusions Oral rehabilitation with dental implants inserted in free flaps for orofacial reconstruction in surgically treated patients with AM can be considered a safe and successful treatment modality.

show abstract

“…[1][2][3] Ameloblastoma is a benign but locally aggressive odontogenic tumor that accounts for 1% of all oral tumors and for 9 to 11% of all odontogenic tumors. Among these factors, orofacial tumors should be highlighted, and ameloblastoma is 1 of the most common tumors associated with this pathology.…”

mentioning

confidence: 99%